Collaboration With the World Health Organization and its Regonal Offices for Global Health Security and the International Health Regulations (IHR 2005)

 

On September 19, 2011, the Government of the United States of America and the World Health Organization (WHO) signed a memorandum of understanding (MOU) to help WHO Member States strengthen their capabilities to support the International Health Regulations (IHR), an international agreement that requires Member States to prevent and respond to acute public health risks that have the potential to cross borders. The MOU includes specific statements that authorize WHO and its regional offices to pursue activities that improve the ability of all nations to detect, report, and respond to infectious diseases quickly and accurately. The purpose is to assist WHO in implementing the MOU regarding the International Health Regulations, including the development and implementation of coordinated plans and networks that enable national governments and regional authorities globally to better address infectious diseases, particularly emerging infections. Specific activities will focus on improving infectious disease surveillance and response; enhancing knowledge generation, innovation, and tools for improved management that build public health infrastructure and strengthen regional health leadership and collaboration; sharing knowledge, tools and other resources in support of applied epidemiology; and developing improved infectious disease surveillance, prevention and control strategies.

General information about this opportunity
Last Known Status
Active
Program Number
93.099
Federal Agency/Office
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention
Type(s) of Assistance Offered
Cooperative Agreements
Program Accomplishments
Fiscal Year 2014: NA. Fiscal Year 2015: Two applications will be received and two awards will be granted. Fiscal Year 2016: It is anticipated that two applications will be received and two awards will be granted.
Authorization
Public Health Service Act, Section 307 as amended [42 U.S.C. §§ 241 and 2421].
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Only the World Health Organization and its regional offices are eligible to apply. For purposes of this document, the term “WHO” includes its regional offices (e.g., PAHO, EMRO, AFRO, SEARO, etc). WHO is the only international and intergovernmental agency qualified to conduct activities under this cooperative agreement because:
• WHO is an international public health agency that works to improve health and living standards globally. WHO is part of the United Nations system. As such, WHO has a unique position among the world’s health agencies as the lead technical agency for health globally. For additional information, please see http://www.who.org
• WHO and its Regional Offices are at the apex of global public health organizations and thus have an exclusive status as the United States government’s key partners for global public health.
• On September 19, 2011, the Government of the United States of America and the World Health Organization signed a memorandum of understanding (MOU) to help developing nations strengthen their capabilities to support the International Health Regulations (IHR). The IHR (2005) is an international agreement that requires WHO Member States to prevent and respond to acute public health risks that have the potential to cross borders and threaten people worldwide. The U.S. Government and WHO share a commitment to strengthen cooperation in the area of global health security to ensure that the international community effectively manages public health risks. Improving the ability of all nations to detect, report, and respond to infectious diseases quickly and accurately lies at the heart of the global community’s ability to address all infectious disease threats, as reflected in the IHR. The MOU establishes a framework for collaboration in line with the provisions set forth in the IHR, which provides a construct for coordinating the management of actions in the event of a public health emergency of international concern. The MOU was signed by Secretary Kathleen Sebelius, Department of Health and Human Services, and Director-General Margaret Chan, World Health Organization, and subsequently by Ambassador Betty E. King, United States Permanent Representative to the United Nations in Geneva. The full text of the MOU can be accessed at: http://www.globalhealth.gov/global-health-topics/health-diplomacy/agreements-and-regulations/20110922-mem.html.
• The MOU includes the following specific statements that support sole-source consideration of WHO and its regional offices (including PAHO) for funding activities that fall under the scope of the MOU: Section 8.a.: “The United States Department of Health and Human Services (DHHS) continues to serve as the primary substantive interface with WHO on global health and health security. DHHS plans to ensure coordination with other U.S. Government departments, agencies, and entities that collaborate on health matters within the scope of this Memorandum to enhance the effectiveness of such activities. The U.S. Government agencies intend to develop programs and provide funds through mechanisms that may be determined jointly by the U.S. Government agency and WHO.” Section 8.b.: “Specific funding mechanisms are intended to be developed and U.S. Government agencies intend to collaborate with WHO to define specific work to be undertaken by the Participants and the division of responsibilities.”.
Beneficiary Eligibility
The World Health Organization and its regional offices work will benefit individuals worldwide, including in the U.S., through collaboration with National Ministries of Health and other organizations/institutions.

The purpose is to support WHO to reduce the global disease burden through improved international capacity to detect and respond to emerging infectious diseases and other threats.
Credentials/Documentation
No Credentials or documentation are required. This program is excluded from coverage under 2 CFR 200, Subpart E - Cost Principles.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.
Application Procedure
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Applicants must download and submit the SF424 application package associated with specific Funding Opportunity Announcements (FOAs) issued by CDC via Grants.gov. Specific application instructions will be included in the FOAs. Applications are not solicited nor will they be accepted outside of a published FOA process.
Award Procedure
Eligible applications submitted in response to published FOAs will be initially reviewed for completeness by the Procurement and Grants Office (PGO) staff. In addition, eligible applications will be jointly reviewed for responsiveness by CDC program staff and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified the application did not meet eligibility and/or published submission requirements. A review will be conducted to evaluate the eligible, complete, and responsive applications according to the criteria listed in the applicable FOA. As part of the review process, the applicant will receive a written Technical Review that summarizes the review findings regarding strengths, weaknesses, and recommendations. The eligible application will be selected and funded based on the findings of the review process. Successful applicants will receive a Notice of Award (NoA) from the CDC Procurement and Grants Office. The NoA shall be the only binding, authorizing document between the recipient and CDC. Unsuccessful applicants will receive notification of the results of the application review by mail. here to enter text.
Deadlines
Contact the headquarters or regional office, as appropriate, for application deadlines.
Approval/Disapproval Decision Time
From 30 to 60 days.
Appeals
Not Applicable.
Renewals
Awards under this Program are typically issued for 1- to 5-year project periods. Renewals at the end of each project period are expected to be made available via publishing of a new/continuation FOA with a complete application and review/award process as described above. Annual renewals within an awarded multi-year project period are made via a non-competitive process.
How are proposals selected?
Applications are reviewed against specific Evaluation Criteria published in the Funding Opportunity Announcements under this program. Evaluation Criteria typically evaluates how well the application demonstrates or illustrates quality, experience, etc., in the areas of background/understanding of the public heatlh problem(s), operational plan, technical approach, plan for evaluation and monitoring, staffing, appropriateness of requested budget, etc.
How may assistance be used?
Support implementation of the IHR by analyzing regional, national, and local resources devoted to infectious diseases and identifying areas for implementation of infectious disease activities consistent with the purpose of this cooperative agreement. Develop, implement, and conduct projects to enhance infectious disease surveillance, response, prevention, and control. Srengthen regional and national public health networks and inter-sectorial co-operation and collaborate with other health organizations, academic institutions, and community groups as appropriate to accomplish program activities. Strengthen regional and national public health leadership and collaboration. Monitor and evaluate overall program performance and the progress of individual projects or activities. Publish and disseminate findings, program evaluations, and lessons learned. • Recipients may not use funds for research.
• Recipients may not use funds for clinical care.
• Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual.
• Awardees may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget.
• The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible.
• Reimbursement of pre-award costs is not allowed.
What are the requirements after being awarded this opportunity?
Reporting
Federal Funding Accountability And Transparency Act Of 2006 (FFATA): Public Law 109-282, the Federal Funding Accountability and Transparency Act of 2006 as amended (FFATA), requires full disclosure of all entities and organizations receiving Federal funds including grants, contracts, loans and other assistance and payments through a single publicly accessible Web site, www.USASpending.gov. The Web site includes information on each Federal financial assistance award and contract over $25,000, including such information as:
1. The name of the entity receiving the award
2. The amount of the award
3. Information on the award including transaction type, funding agency, etc.
4. The location of the entity receiving the award
5. A unique identifier of the entity receiving the award; and
6. Names and compensation of highly-compensated officers (as applicable)

Compliance with this law is primarily the responsibility of the Federal agency. However, two elements of the law require information to be collected and reported by recipients: 1) information on executive compensation when not already reported through the Central Contractor Registry; and 2) similar information on all sub-awards/subcontracts/consortiums over $25,000.

For the full text of the requirements under the Federal Funding Accountability and Transparency Act of 2006, please review the following website:
http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_cong_bills&docid=f:s2590enr.txt.pdf .

Each funded applicant must provide CDC with an annual Interim Progress Report submitted via www.grants.gov:
1. The interim progress report is due no less than 90 days before the end of the budget period. The Interim Progress Report will serve as the non-competing continuation application, and must contain the following elements:
a. Standard Form (“SF”) 424S Form.
b. SF-424A Budget Information-Non-Construction Programs.
c. Budget Narrative.
d. Indirect Cost Rate Agreement.
e. Project Narrative.

Additionally, funded applicants must provide CDC with an original, plus two hard copies of the following reports:
2. Financial Status Report* (SF 269) no more than 90 days after the end of the budget period.
3. Final performance and Financial Status Reports*, no more than 90 days after the end of the project period.

*Disclaimer: As of February 1, 2011, current Financial Status Report (FSR) requirements will be obsolete. Existing practices will be updated to reflect changes for implementation of the new Federal Financial Reporting (FFR) requirements.

These reports must be submitted to the attention of the Grants Management Specialist listed in the Section VII below entitled “Agency Contacts”. Cash reports are not applicable. Described above. Described above. Described above.
Auditing
This program is excluded from coverage under 2 CFR 200, Subpart F - Audit Requirements. A-122 and/or international grant language should be cited... not A-133
Records
Financial records, supporting documents, statistical records, and all other records pertinent to the project must be kept readily available for review by personnel authorized to examine PHS grant accounts. Records must be maintained for a minimum of 3 years after the end of a budget period. If questions still remain, such as those raised as a result of an audit, records must be retained until completion or resolution of any audit in process or pending resolution. Property records must be retained in accordance with PHS Grants Policy Statement requirements.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formulas are not applicable to this program.
This program has no matching requirements.
This program does not have MOE requirements.
Length and Time Phasing of Assistance
Assistance is available for a 12-month budget period within a 1- to 5- year project period. After awards are issued, funds are released in a manner and timeline in accordance with the payment procedure established by the grantee institution with DHHS (typically the Payment Management System). See the following for information on how assistance is awarded/released: Funding is awarded in accordance with established procedures for HHS/CDC-funded cooperative agreements.
Who do I contact about this opportunity?
Regional or Local Office
None.
Headquarters Office
Theresa Turski Centers for Disease Control and Prevention
1600 Clifton Road NE
Mail Stop E93, Atlanta, Georgia 30329 Email: tnt7@cdc.gov Phone: 404-639-7411
Website Address
http://www.cdc.gov
Financial Information
Account Identification
75-0943-0-1-550 - CDC annual appropriations.
Obligations
(Cooperative Agreements) FY 14 $608,612; FY 15 est $18,877,855; and FY 16 est $22,000,000 - This program includes awards made under two cooperative agreements (PAHO & WHO). In 2013, awards made to WHO fell under CFDA 93.283, so the actual award for FY13 under this CFDA is substantially less than initially estimated because it only includes the award to PAHO. WHO was moved to CFDA 93.099 in 2014 and so the FY14 includes awards made for both coags.
Range and Average of Financial Assistance
Awards ranged and averaged between $600K (PAHO) and $18M (WHO).
Regulations, Guidelines and Literature
Regulations governing this program are published in the specific Funding Opportunity Announcements and identified on the notices of award.
Examples of Funded Projects
Fiscal Year 2014: No Current Data Available Fiscal Year 2015: Funded projects include international epidemiologic and laboratory surveillance capacity expansion and maintenance. Fiscal Year 2016: Funded projects include international epidemiologic and laboratory surveillance capacity expansion and maintenance.